-
Study aim
-
To compare the outcomes of transurethral resection of the prostate (TURP) and TURP plus Botox injection in benign prostatic hyperplasia (BPH) patients.
-
Design
-
In this pragmatic double-blind clinical trial, fifty patients with BPH were assigned into parallel groups using the table of random numbers in a community-based setting.
-
Settings and conduct
-
BPH patients at Imam Reza Hospital, Mashhad, Iran, were chosen. In this double-blind study, the clinical care provider and data collector were blind to group assignment and the type of treatment.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: Age range of 50-80 years, lower urinary tract symptoms resistant to standard medical treatment, international prostate symptom score (IPSS) of > 12, and prostate volume of >50 cm3 in ultrasound.
Exclusion criteria: History of prostate surgery, prostate cancer, bleeding disorders, and incidence of acute urinary retention during the treatment.
-
Intervention groups
-
The intervention Group I will undergo TURP. The intervention Group II will concurrently receive TURP and 300 U intravenous Botox at 30 different locations.
-
Main outcome variables
-
Evaluation and comparison of clinical symptoms (e.g., dysuria, urinary frequency, and pelvic pain) based on the IPSS 3, 6, and 12 months after the intervention in both groups.